Overview
- Luigi Mangione, who is accused of killing UnitedHealthcare CEO Brian Thompson in December 2024, attended a federal pretrial hearing on Monday to discuss juror questionnaires, jury selection and trial timing.
- A federal judge in January threw out the murder and weapons counts, leaving only a stalking charge in the federal case and removing federal death‑penalty exposure.
- Reports that federal prosecutors and Mangione’s defense held plea talks were published by anonymous sources, but his lawyers have publicly denied those reports.
- The federal scheduling dispute matters because Mangione faces a separate state murder trial that is set to begin with jury selection on Sept. 8, creating a clash over witnesses, juror pools and courtroom logistics.
- The case has attracted public attention and vocal supporters of critics of the health‑insurance industry, a factor defense attorneys say raises risks to juror impartiality and could shape pretrial strategy and negotiations.